Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Altman Z-score

Arena Pharmaceuticals Altman Z-score Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Altman Z-score from 2000 to 2018.
  • Arena Pharmaceuticals Altman Z-score for the quarter ending September 09, 2018 was 11.96 a 105.70% increase of 12.64 year over year
  • Arena Pharmaceuticals Altman Z-score for the last 12 months ending September 09, 2018 was 9.89 a 130.04% increase of 12.86 year over year
  • Arena Pharmaceuticals Annual Altman Z-score for 2017 was -2.97 a -194.78% increase of 5.79 from 2016
  • Arena Pharmaceuticals Annual Altman Z-score for 2016 was -8.76 a 35.94% decrease of -3.15 from 2015
  • Arena Pharmaceuticals Annual Altman Z-score for 2015 was -5.61 a 29.08% decrease of -1.63 from 2014
Other Balance Sheet Metrics:
  • Arena Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $610m a 44.38% increase of 271m year over year
  • Arena Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
  • Arena Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $531m a 61.01% increase of 324m year over year
View Chart On Koyfin

Quarterly ARNA Altman Z-score Data

09/201811.96
06/201813.17
03/20186.71
12/2017-0.68
09/2017-1.75
06/2017-9.26
03/2017-13.91
09/2016-8.21
06/2016-8.46
03/2016-7.30

Annual ARNA Altman Z-score Data

2017-2.97
2016-8.76
2015-5.61
2014-3.98
2013-0.55
2012-1.61
2011-10.00
2010-4.52
2009-5.17
2008-5.03